AlzeCure Pharma AB's market cap is currently €26.61M. The company's EPS TTM is €-0.009438134999999999; its P/E ratio is ―; AlzeCure Pharma AB is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
